comparemela.com

Page 3 - Lumicks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nature Paper Identifies Avidity Escape As Solid Tumor Evasion Mechanism of CAR T Cell Cancer Therapies

/PRNewswire/ LUMICKS, a leading life science tools company developing instruments and consumables for dynamic single-molecule and cell avidity analysis,.

United statesNoord hollandMarcelav mausAndrea candelliKassandra barbetseaBroad instituteResearch revealed the importance of testingCellular immunotherapy program at massachusettsProfessor of medicine at harvard medical schoolHarvard medical schoolResearch revealedSolid tumorsReduce failure ratesMassachusetts general hospitalCell avidity analyzerAssociate professor

New Customer Installation of LUMICKS z-Movi Cell Avidity Analyzer Confirms Value of Cell Avidity Measurement in Leading Labs Studying Biomarkers of Immune Oncology

New Customer Represents Leading-Edge Scientific Research AMSTERDAM, April 21, 2022 /PRNewswire/ LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule

Noord hollandKassandra barbetseaDirk buschElvira dippolitoTechnical university of munichSchool of medicineBusch labEdge scientific researchNew customer represents leading edge scientificAvidity analyzerMedical microbiologyTechnical universityElvirad ippolitoGerrit sittersGeneral managerAvidity business

New Customer Installation of LUMICKS z-Movi® Cell Avidity Analyzer Confirms Value of Cell Avidity Measurement in Leading Labs Studying Biomarkers of Immune Oncology

/PRNewswire/ LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced.

Noord hollandKassandra barbetseaDirk buschElvira dippolitoTechnical university of munichSchool of medicineBusch labEdge scientific researchNew customer represents leading edge scientificCell avidity analyzerMedical microbiologyTechnical universityElvirad ippolitoGerrit sittersGeneral managerAvidity business

LUMICKS Strengthens its Innovative C-Trap Solution with Launch of New Lakeview Analysis Software Platform

Lakeview software enables easier data analysis, solidifying the end-to-end C-Trap solution for dynamic single-molecule analysis, and democratizing use by researchers AMSTERDAM, April 5

United statesNoord hollandJos maasKassandra barbetseaExperimental biologyGeneral managerLakeview platformDynamic single moleculeCell avidityLabel free microscopyAvidity analyzer

LUMICKS Strengthens its Innovative C-Trap® Solution with Launch of New Lakeview Analysis Software Platform

/PRNewswire/ LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule (DSM) and cell avidity (CA) analysis to.

United statesNoord hollandJos maasKassandra barbetseaExperimental biologyGeneral managerLakeview platformDynamic single moleculeCell avidityOptical tweezersLabel free microscopyCell avidity analyzer

vimarsana © 2020. All Rights Reserved.